SDV Evolution
What SDV is really for? How it develops and to what form it evolves? What is the future role of a CRA? This article depicts a role of SDV in a clinical monitoring process, shows the path of [...]
Mar
2016
Dec
2015
EarlyBird Ver. 3.5 available in SandBox
Cyntegrity has updated the SandBox environment with the Version 3.5 of the RBM solution EarlyBird. The most informative & understandable graphs, robust KRIs, clear performance indicators will turn your experience with RBM analytics to a real adventure! Test it yourself. Free. [...]
Apr
2015
Meet Cyntegrity at German ePharma Day on 11th of June 2015 in Munich
Cyntegrity's CEO Artem Andrianov to speak on the Germany ePharma day in Munich. The topic of the presentation is Practical methods how to master the new EU Clinical Trials Regulation with risk-based monitoring (RbM) See conference's program here. The event is focused on the new EU regulation [...]
Dec
2014
Duality of Risk-based Monitoring Definition: EMA vs FDA
In October 2014 at the Risk-based Monitoring conference in Copenhagen the Senior Director QA Operations of Janssen, Jan Van Parijs said: "Industry is historically heavily regulated, so as an industry we are kind of used to the fact that the authorities provide a set [...]